Chrousos Phaedra — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Chrousos Phaedra has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Phaedra Chrousos is an individual referenced in SEC filings for Vanda Pharmaceuticals Inc. as of June 8, 2026. The filing context identifies her by the name Chrousos Phaedra (likely representing the given name Phaedra and surname Chrousos) and indicates an association with Vanda Pharmaceuticals. Beyond this SEC context, publicly verifiable biographical details (such as a confirmed job title, career background, or notable achievements) are not readily available. The name may appear in other variations (e.g., Phaedra Chrousos) in corporate disclosures or leadership rosters, but a definitive public profile is not established in widely accessible sources. For reference, Vanda Pharmaceuticals’ corporate site is vandapharma.com.
Phaedra Chrousos is an individual referenced in SEC filings for Vanda Pharmaceuticals Inc. as of June 8, 2026. The filing context identifies her by the name Chrousos Phaedra (likely representing the given name Phaedra and surname Chrousos) and indicates an association with Vanda Pharmaceuticals. Beyond this SEC context, publicly verifiable biographical details (such as a confir…
How many SEC Form 4 filings has Chrousos Phaedra submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Chrousos Phaedra's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
